Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus

N Mungan1, B Yuksel, M Bakman

  • 1Division of Pediatric Endocrinology and Metabolism, Cukurova University, Faculty of Medicine, Adana, Turkey. byuksel@mail.cu.edu.tr

Indian Pediatrics
|May 28, 2003
PubMed

Insights

Urinary N-acetyl-beta-D-glucosaminidase (NAG) is elevated in children with type 1 diabetes, but doesn't reliably predict diabetic nephropathy. Elevated NAG is linked to puberty, not albuminuria markers.

Area of Science:

  • Pediatrics
  • Nephrology
  • Endocrinology

Background:

  • Type 1 diabetes mellitus (T1DM) in children and adolescents can lead to diabetic nephropathy.
  • Early detection of kidney damage is crucial for managing T1DM complications.
  • Urinary N-acetyl-beta-D-glucosaminidase (NAG) is a potential biomarker for kidney injury.

Purpose of the Study:

  • To investigate urinary albumin excretion rate (AER) and NAG activity in pediatric T1DM patients.
  • To assess the relationship between AER, NAG activity, and factors like disease duration, HbA1c, hypertension, and puberty.
  • To determine if urinary NAG activity is a useful marker for early diabetic nephropathy detection in this population.

Main Methods:

  • Measured urinary albumin excretion rate (AER) and N-acetyl-beta-D-glucosaminidase (NAG) activity in 44 children and adolescents with T1DM.
  • Compared patient values to controls.
  • Analyzed correlations between AER, NAG activity, disease duration, HbA1c, diastolic blood pressure, and pubertal status.

Main Results:

  • Both AER and urinary NAG activity were significantly higher in T1DM patients compared to controls.
  • Microalbuminuria was observed in 15.9% of patients, all of whom were pubertal.
  • AER correlated significantly with disease duration, HbA1c, diastolic blood pressure, and puberty.
  • No correlation was found between AER and urinary NAG activity.
  • Puberty was an independent factor for elevated urinary NAG activity, but NAG was not significantly correlated with other microalbuminuria-related variables.

Conclusions:

  • Urinary NAG activity is elevated in children and adolescents with T1DM.
  • Elevated urinary NAG is associated with puberty but not with AER-related factors indicative of early nephropathy.
  • Urinary NAG activity does not appear to be a reliable marker for the early detection of diabetic nephropathy in pediatric T1DM patients.

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...